nach oben

Rheumatology International

Erschienen in:

27.09.2021 | Case Based Review

Catatonia in systemic lupus erythematosus: case based review

verfasst von: T. G. Sundaram, Hafis Muhammed, Latika Gupta, Able Lawrence, Ramnath Misra, Amita Aggarwal

Erschienen in: Rheumatology International | Ausgabe 8/2022

Einloggen, um Zugang zu erhalten

Abstract

Catatonia is a rare psychomotor syndrome characterized by stupor, posturing and echophenomena. It can be associated with schizophrenia, infections, drugs and autoimmune causes like anti N-methyl D-aspartate (NMDA) receptor encephalitis and systemic lupus erythematosus (SLE). Here we report two cases of systemic lupus erythematosus with catatonia, who improved with immunosuppressive treatment and review the cases described in the literature. The first case presented with fever, pancytopenia, toxic epidermal necrolysis (TEN)-like rash and later developed catatonia and macrophage activation syndrome (MAS). The second case presented with acute cutaneous lupus erythematosus (ACLE), fever, alopecia, polyarthralgias, nephritis, cytopenias along with catatonia. Successful management of this syndrome requires prompt recognition and treatment with immunosuppression as well as benzodiazepines with or without electroconvulsive therapy (ECT).

Unterman A, Nolte JES, Boaz M, Abady M, Shoenfeld Y, Zandman-Goddard G (2011) Neuropsychiatric syndromes in systemic lupus erythematosus: a meta-analysis. Semin Arthritis Rheum 41:1–11CrossRef

The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes (1999) Arthritis Rheum 42:599–608

Rogers JP, Pollak TA, Blackman G, David AS (2019) Catatonia and the immune system: a review. Lancet Psychiatry 6:620–630CrossRef

Beil EF, Vora SS (2020) Malignant catatonia after antipsychotic and high-dose steroid use in a teenager with neuropsychiatric systemic lupus erythematosus. J Clin Rheumatol. https://doi.org/10.1097/RHU.0000000000001481CrossRef

American Psychiatric Association (2013) American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 5th edn. Arlington

Austin HA, Klippel JH, Balow JE, le Riche NG, Steinberg AD, Plotz PH et al (1986) Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs. N Engl J Med 314:614–619CrossRef

Mahendra B (1981) Where have all the catatonics gone? Psychol Med 11:669–671CrossRef

Walther S, Stegmayer K, Wilson JE, Heckers S (2019) Structure and neural mechanisms of catatonia. Lancet Psychiatry 6:610–619CrossRef

Barry H, Susan B, Barrett E, Murphy KC, Cotter DR (2015) Anti-N-methyl-d-aspartate receptor encephalitis: review of clinical presentation, diagnosis and treatment. BJPsych Bull 39:19–23. https://doi.org/10.1192/pb.bp.113.045518CrossRefPubMedPubMedCentral

10.

Inagaki T, Kudo K, Kurimoto N, Aoki T, Kuriyama K (2020) A case of prolonged catatonia caused by Sjögren’s syndrome. Case Reports Immunol 3:8881503. https://doi.org/10.1155/2020/8881503CrossRef

11.

Boeke A, Pullen B, Coppes L, Medina M, Cooper JJ (2018) Catatonia associated with systemic lupus erythematosus (SLE): a report of two cases and a review of the literature. Psychosomatics 59:523–530CrossRef

12.

Jones M, Gausche E, Reed E (2016) A case of neuropsychiatric lupus with severe malignant catatonia that improved with daily electroconvulsive therapy. J Neuropsychiatry Clin Neurosci 28:e19–e20CrossRef

13.

Hussain A, Mir TH, Dar MA et al (2015) Systemic lupus erythematous presenting as catatonia and its response to electroconvulsive therapy. Indian J Psychol Med 37:456–459CrossRef

14.

Bica BE, Moro AL, Hax V, Nicol NA, Campos GS, Rivera LM, da Costa AF, Xavier RM, Monticielo OA (2015) Electroconvulsive therapy as a treatment for refractory neuropsychiatric lupus with catatonia: three case studies and literature review. Lupus 24:1327–1331CrossRef

15.

Canders CP, Terry GE, Clark G (2015) Low doses of benzodiazepines for catatonia associated with systemic lupus erythematosus. J Neuropsychiatry Clin Neurosci 27(2):e146–e148CrossRef

16.

Chaudhury D, Qureshi A, Prasad S, Meena RK, Sharma S (2017) Catatonia—an unusual presenting clinical manifestation of systemic lupus erythematosus. Reumatol Clin 13:224–226CrossRef

17.

Leon T, Aguirre A, Pesce C, Sanhueza P, Toro P (2014) Electroconvulsive therapy for catatonia in juvenile neuropsychiatric lupus. Lupus 23:1066–1068CrossRef

18.

Ali A, Taj A, uz-Zehra M, (2014) Lupus catatonia in a young girl who presented with fever and altered sensorium. Pak J Med Sci 30:446–448PubMedPubMedCentral

19.

Cristancho P, Jewkes D, Mon T, Conway C (2014) Successful use of right unilateral ECT for catatonia: a case series. J ECT 30:69–72CrossRef

20.

Grover S, Parakh P, Sharma A, Rao P, Modi M, Kumar A (2013) Catatonia in systemic lupus erythematosus: a case report and review of literature. Lupus 22:634–638CrossRef

21.

Grover S, Singh A, Sarkar S, Bhalla A (2013) SLE presenting with catatonia in an adolescent girl. J Pediatr Neurosci 8:262–263CrossRef

22.

Mon T, L’Ecuyer S, Farber NB, White AJ, Baszis KW, Hearn JK et al (2012) The use of eletroconvulsive therapy in a patient with juvenile systemic lupus erythematosus and catatonia. Lupus 21:1575–1581CrossRef

23.

Pustilnik S, Trutia A (2011) Catatonia as the presenting symptom in systemic lupus erythematosus. J Psychiatr Pract 17:217–221CrossRef

24.

Fam J, Lee TS, Lee HY, Ng BY (2010) Electroconvulsive therapy for catatonia in neuropsychiatric systemic lupus erythematosus. J ECT 26:143–144CrossRef

25.

Brelinski L, Cottencin O, Guardia D, Anguill JD, Queyrel V, Hatron PY et al (2009) Catatonia and systemic lupus erythematosus: a clinical study of three cases. Gen Hosp Psychiatry 31:90–92CrossRef

26.

Alao AO, Chlebowski S, Chung C (2009) Neuropsychiatric systemic lupus erythematosus presenting as bipolar I disorder with catatonic features. Psychosomatics 50:543–547CrossRef

27.

Marra D, Amoura Z, Soussan N (2008) Plasma exchange in patients with stuporous catatonia and systemic lupus erythematosus. Psychother Psychosom 77:195–196CrossRef

28.

Wang HY, Huang TL (2006) Benzodiazepines in catatonia associated with systemic lupus erythematosus. Psychiatry Clin Neurosci 60:768–770CrossRef

29.

Perisse D, Amoura Z, Cohen D (2003) Case study: effectiveness of plasma exchange in an adolescent with systemic lupus erythematosus and catatonia. J Am Acad Child Adolesc Psychiatry 42:497–499CrossRef

30.

Malur C, Pasol E, Francis A (2001) ECT for prolonged catatonia. J ECT 17:55–59CrossRef

31.

Fricchione GL, Kaufman LD, Gruber BL, Fink M (1990) Electroconvulsive therapy and cyclophosphamide in combination for severe neuropsychiatric lupus with catatonia. Am J Med 88:442–443CrossRef

32.

Lanham JG, Brown MM, Hughes GR (1985) Cerebral systemic lupus erythematosus presenting with catatonia. Postgrad Med J 61:329–330CrossRef

33.

Tishler M, Abramov AL (1985) Systemic lupus erythematosus presenting as catatonic schizophrenia. Clin Rheumatol 4:340–342CrossRef

34.

Consoli A, Raffin M, Laurent C, Bodeau N, Campion D, Amoura Z, Sedel F, An-Gourfinkel I, Bonnot O, Cohen D (2012) Medical and developmental risk factors of catatonia in children and adolescents: a prospective case-control study. Schizophr Res 137(1–3):151–158CrossRef

35.

Kim DD, Ho C, King R, Morrow SA (2018) Pearls & Oy-sters: an unusual neuropsychiatric manifestation of systemic lupus erythematosus. Neurology 90(21):e1929–e1932. https://doi.org/10.1212/WNL.0000000000005555CrossRefPubMed

36.

Bhangle SD, Kramer N, Rosenstein ED (2013) Corticosteroid-induced neuropsychiatric disorders: review and contrast with neuropsychiatric lupus. Rheumatol Int 33:1923–1932CrossRef

37.

Sienaert P, Dhossche DM, Vancampfort D, De Hert M, Gazdag G (2014) A clinical review of the treatment of catatonia. Front Psychiatry 5:181CrossRef

Titel: Catatonia in systemic lupus erythematosus: case based review
verfasst von: T. G. Sundaram
Hafis Muhammed
Latika Gupta
Able Lawrence
Ramnath Misra
Amita Aggarwal
Publikationsdatum: 27.09.2021
Verlag: Springer Berlin Heidelberg
Erschienen in: Rheumatology International / Ausgabe 8/2022
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI: https://doi.org/10.1007/s00296-021-05006-y

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Neue S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Schadet Ärger den Gefäßen?

14.05.2024 Arteriosklerose Nachrichten

In einer Studie aus New York wirkte sich Ärger kurzfristig deutlich negativ auf die Endothelfunktion gesunder Probanden aus. Möglicherweise hat dies Einfluss auf die kardiovaskuläre Gesundheit.

Intervallfasten zur Regeneration des Herzmuskels?

14.05.2024 Herzinfarkt Nachrichten

Die Nahrungsaufnahme auf wenige Stunden am Tag zu beschränken, hat möglicherweise einen günstigen Einfluss auf die Prognose nach akutem ST-Hebungsinfarkt. Darauf deutet eine Studie an der Uniklinik in Halle an der Saale hin.

Klimaschutz beginnt bei der Wahl des Inhalators

14.05.2024 Klimawandel Podcast

Auch kleine Entscheidungen im Alltag einer Praxis können einen großen Beitrag zum Klimaschutz leisten. Die neue Leitlinie zur "klimabewussten Verordnung von Inhalativa" geht mit gutem Beispiel voran, denn der Wechsel vom klimaschädlichen Dosieraerosol zum Pulverinhalator spart viele Tonnen CO₂. Leitlinienautor PD Dr. Guido Schmiemann erklärt, warum nicht nur die Umwelt, sondern auch Patientinnen und Patienten davon profitieren.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2022

Nailfold capillaroscopy changes associated with anti-RNP antibodies in systemic lupus erythematosus

Comparative effectiveness of trimethoprim-sulfamethoxazole versus atovaquone for the prophylaxis of pneumocystis pneumonia in patients with connective tissue diseases receiving prolonged high-dose glucocorticoids

Clinical, radiologic and serologic profile of patients with interstitial pneumonia with autoimmune features: a cross-sectional study

Tacrolimus induces remission in refractory and relapsing lupus nephritis by decreasing P-glycoprotein expression and function on peripheral blood lymphocytes

Lymphocyte subsets in the peripheral blood are disturbed in systemic sclerosis patients and can be changed by immunosuppressive medication